A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant

Protocol No

IIT-ABEDIN-PREEMPT

Staff Member

Sameem Abedin

Phase

II

Summary

In this project we want to find out more about the benefit of providing maintenance therapy for individuals with myeloid disorders following HCT based on measurable residual disease levels taken prior to HCT procedures.

Objective

A Phase II Study to Prevent Relapse for Myeloid Malignancies with Measurable Disease

Status

OPEN TO ACCRUAL